Full Length Research Paper
References
|
Van de Beek D, de Gans J, Spanjaard L, Dankert J (2002). Antibiotic guidelines and antibiotic use in adult bacterial meningitis in The Netherlands. J. Antimicrob Chemother. 49(4):661-6. Crossref |
||||
|
Lepur D, Baršić B (2007). Community-Acquired Bacterial Meningitis in Adults: Antibiotic Timing in Disease Course and Outcome. Infection 35(4):225-31. Crossref |
||||
|
Van de Beek D, De Gans J, Spanjaard L, Weisfelt M, Reitsma JB, Vermeulen M (2004a). Clinical Features and Prognostic Factors in Adults with Bacterial Meningitis. New Engl. J. Med. 351(18):1849-59. Crossref |
||||
|
Cullen MM (2005). An audit of the investigation and initial management of adults presenting with possible bacterial meningitis. J. Infect. 50(2):120-4. Crossref |
||||
|
Van de Beek D, de Gans J, Tunkel AR, Wijdicks EF (2006). Community acquired bacterial meningitis in adults. N. Engl. J. Med. 354(1):44-53. Crossref |
||||
| Fitch MT, van de Beek D (2007). Emerg. Diagn. Treatment Adult Meningitis 7(3):191-200. | ||||
|
Heyderman RS, Lambert HP, O'Sullivan I, Stuart JM, Taylor BL, Wall RA (2003). Early management of Suspected Bacterial Meningitis and Meningococcal Septicaemia in Adults. J. Infect. 46(2):75-7. Crossref |
||||
|
Van de Beek D, De Gans J, McIntyre P, Prasad K (2004b). Steroids in adults with acute bacterial meningitis: a systematic review. Lancet Infect. Dis. 4(3):139-43. Crossref |
||||
| Begg N, Cartwright J, Cohen EB, Kaczmarski EB, Innes JA, Leen CL, Nathwani D, Singer M, Southgate L, Todd WT, Welsby PD, Wood MJ (1999). Consensus Statement on Diagnosis, Investigation, Treatment and Prevention of Acute Bacterial Meningitis in Immunocompetent Adults J. Infect. 39(1):1-15. | ||||
|
O'Donnell EP, Hurt KM, Scheetz MH, Postelnick MJ, Scarsi KK (2009). Empiric antibiotic selection for infectious emergencies: bacterial pneumonia, meningitis and sepsis. Drugs Today (Barc). 45(5):379-93. Crossref |
||||
|
Korshin A, Køster-Rasmussen R, Meyer CN. Danish Bacterial Meningitis Group (2007). Adjunctive steroid treatment: local guidelines and patient outcome in adult bacterial meningitis. Scand J. Infect. Dis. 39(11-12):963-8. Crossref |
||||
|
Peterković V, Trkulja V, Kutleša M, Krajinović V, Lepur D (2012). Dexamethasone for adult community-acquired bacterial meningitis: 20 years of experience in daily practice. Neurology 259(2):225-36 Crossref |
||||
|
Chadwick DR, Lever AML (2002). The impact of new diagnostic methodologies in the management of meningitis in adults at a teaching hospital. QJM 95(10):663-70. Crossref |
||||
|
Gjini AB, Stuart JM, Cartwright K, Cohen J, Jacobs M, Nichols T, Ninis N, Prempeh H, Whitehouse A, Heyderman RS (2006). Quality of in-hospital care for adults with acute bacterial meningitis: a national retrospective study. QJM 99(11):761-9. Crossref |
||||
|
Sáez -Llorens X, O'Ryan M (2001). Cefepime in the empiric treatment of meningitis in children. Pediatr. Infect. Dis. J. 20 (3):356-61. Crossref |
||||
| Mitropoulos IF, Hermsen DE, Rotschafer CJ (2008). Central Nervous System Infections. In: Pharmacotherapy-A pathophysiologic approach. McGraw – Hill. pp 1923-1942. | ||||
|
Chaudhuri A, Martin PM, Kennedy PG, Andrew Seaton R, Portegies P, Bojar M, Steiner I, EFNS Task Force (2008). EFNS guideline on the management of community-acquired bacterial meningitis: report of an EFNS Task Force on acute bacterial meningitis in older children and adults. Eur. J. Neurol. 15 (7):649-59. Crossref |
||||
|
Solomon T, Hart IJ, Beeching NJ (2007). Viral encephalitis: a clinician's guide. Pract. Neurol. 7(5):288-305. Crossref |
||||
|
Tunkel AR, Hartmen BJ, Kaplan SL, Kaufman BA, Roos KL, Scheld WM, Richard JW (2004). Practice Guidelines for the Management of Bacterial Meningitis by The Infectious Diseases Society of America. Clin. Infect. Dis. 39(9):1267-84. Crossref |
||||
|
Stockdale AJ, Weekes MP, Aliyu SH (2011). An audit of acute bacterial meningitis in a large teaching hospital 2005-10. QJM 104(12):1055-63. Crossref |
||||
|
Georges H, Chiche A, Alfandari S, Devos P, Boussekey N, Leroy O (2009). Adult community-acquired bacterial meningitis requiring ICU admission: epidemiological data, prognosis factors and adherence to IDSA guidelines. Eur. J. Clin. Microbiol. Infect. Dis. 28(11):1317-25. Crossref |
||||
|
Zimmerli W (2003). Acute bacterial meningitis: a time for a better outcome. Intensive Care Med. 29(11):1868-70. Crossref |
||||
| Brouwer MC, McIntyre P, de Gans J, Prasad K, van de Beek D (2010). Corticosteroids for acute bacterial meningitis. Cochrane Database Syst. Rev. 8(9):1-73. | ||||
|
Auburtin M, Wolff M, Charpentier J, Varon E, Le Tulzo Y, Girault C, Mohammedi I, Renard B, Mourvillier B, Bruneel F, Ricard JD, Timsit JF (2006). Detrimental role of delayed antibiotic administration and penicillin-nonsusceptible strains in adult intensive care unit patients with pneumococcal meningitis: the PNEUMOREA prospective multicenter study. Crit. Care Med. 34(11):2758-65. Crossref |
||||
|
Køster-Rasmussen R, Korshin A, Meyer CN (2008). Antibiotic treatment delay and outcome in acute bacterial meningitis. J. Infect. 57(6):449-54. Crossref |
||||
|
Proulx N, Frechette D, Toye B. Chan J, Kravcik S (2005). Delays in the administration of antibiotics are associated with mortality from acute bacterial meningitis. QJM 98(4):291-8. Crossref |
||||
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
